No significant association was found between LMP-1, LMP-2 expression and other clinical characteristics, such as patient’s gender (LMP-1: p = 0.06; LMP-2: p = 0.83), age (LMP-1: p = 0.19; LMP-2: p = 0.26), tumor histological types (LMP-1: p = 0.29; LMP-2: p = 0.28), as well as stage (LMP-1: p = 0.07; LMP-2: p = 0.40). The gene discussed is PSMB9; the disease is neoplasm.